Introduction {#Sec1}
============

Oral wounds can be caused by trauma, recurrent ulcers, inflammation, irradiation, and surgery for the extirpation of congenital or pathological lesions. If not properly treated, intraoral wounds can lead to pain, infection, and subsequent undesirable scarring and adhesion, resulting in functional deficits, such as dysphagia, dysarthria, and a poor quality of life. A split-thickness skin graft, local or regional flap transfer, or microvascular free flap transplantation has been used to restore the intraoral surface lining or soft tissue defects; however, an inadequate supply and potential morbidity of donor sites limits the potential use of these methods to cover and treat severe oral wounds. Moreover, a regional or microvascular flap transfer can fill large intraoral soft tissue defects but requires considerable operation time and experienced surgical skills. Moreover, *in vitro*-engineered, cell-based regenerative approaches have been introduced as a feasible alternative method to replace the current standard treatment comprising autologous skin graft or flap transplantation^[@CR1]--[@CR3]^.

Cell sheet engineering techniques exhibit greater restorative efficacy for wounds than cell-based therapies, such as cell injection or spray^[@CR4]^. Epithelial cell sheets prepared from allografts or autografts of epidermal cells have been applied to cover skin defects^[@CR5]--[@CR7]^. Oral mucosal equivalents mimicking the normal oral mucosa have also been engineered *in vitro* for the potential application in treating intraoral defects^[@CR8]--[@CR10]^. Oral mucosal equivalents comprising human lamina propria fibroblasts and oral epithelial cells have exhibited histological and immunohistochemical marker expression similar to that in the normal oral mucosa^[@CR11]^. In addition to large intraoral mucosal defects^[@CR12]^, oral mucosal cell sheets have been applied for restoring other body surface defects, such as the cornea^[@CR13]^ and urinary tract^[@CR14]^. Furthermore, we previously developed an *in vitro*-engineered autologous mucosal cell sheet and demonstrated its efficacy in promoting oral surgical wound healing in a rat tongue excisional model^[@CR15]^.

The post-transplantation survival of grafts or tissue-engineered cell sheets is dependent on a sufficient blood supply in the wound bed^[@CR16]^. During early post-transplantation days, the plasmatic fluid engorges the graft and plasmatic diffusion may be hindered in the wound bed, resulting in hypoxic and ischemic injury of the transplant that leads to graft failure^[@CR17],\ [@CR18]^. Growing evidence has shown that the microvascular pre-formation in cell sheets may accelerate neovascularization, improve the oxygen and nutrient supply, and support cell survival and cell integration with host tissues^[@CR19]^. In addition, fibroblasts promote endothelial cell proliferation and vascular network formation^[@CR20]^. Pre-vascularized mesenchymal stem cell sheets also demonstrate improved full-thickness skin wound repair compared with that demonstrated by cell sheets without pre-vascularization^[@CR21]^. Therefore, we further developed a pre-vascularized oral mucosal cell sheet comprising oral keratinocytes and a pre-vascularized layer containing plasma fibrin, oral fibroblasts, and endothelial progenitor cells (Fig. [1](#Fig1){ref-type="fig"}). Endothelial progenitor cells can be isolated from peripheral blood cells^[@CR22],\ [@CR23]^. The pre-vascularized layer beneath the keratinocyte layer contained pre-formed microvessels generated by isolating and expanding endothelial cells from peripheral blood samples. In the present study, we examined the potential utility of our newly developed pre-vascularized mucosal cell sheets in oral wound healing.Figure 1Schematic drawings and photographs of the *in vitro* engineering technique and *in vivo* testing of the oral mucosal cell sheets. (**A**) *In vitro* culture of oral mucosal and endothelial progenitor cells and *in vitro* engineering of oral mucosal cell sheet without (K sheet) or with pre-vascularization (PV sheet). The endothelial progenitor cells were isolated from peripheral blood samples and expanded. (**B**--**D**) Photographs showing the *in vivo* experimental procedures. A deep surgical wound (arrows) was made in the bilateral buccal region of each Sprague Dawley rat (**B**), a mucosal cell sheet (asterisk) was placed on the surgical defect (arrows) (**C**), and a thin transparent silastic sheet (asterisk) was overlaid on the cell sheet or wound bed (control) (**D**).

Results {#Sec2}
=======

*In vitro* mucosal and endothelial progenitor cell culture {#Sec3}
----------------------------------------------------------

Keratinocytes and fibroblasts from the oral mucosa of all experimental rats were successfully cultured *in vitro*. Keratinocyte and fibroblast colonies were identified in separately cultured dishes of all samples 2--5 days after harvesting and seeding. The cells were grown to reach \> 80% confluence within 10--16 days. No bacterial or fungal contamination was found in any of the sample cultures. Most cultured human keratinocytes and fibroblasts exhibited greater than 80% viability when examined with vital dye prior to harvesting for the generation of the cell sheet. Endothelial cell colonies from peripheral blood were observed on the collagen-coated plates by approximately day 7. The cell expansion was successfully achieved in all blood samples with endothelial cell colony formation. Moreover, the cells retained the endothelial cell morphology of cobblestone-like monolayers, as well as CD31-positive and calcein AM-positive immunostaining (Fig. [2](#Fig2){ref-type="fig"}). Capillary tube formation was observed by the formation of capillary-like structures in Matrigel assays.Figure 2Characteristics of the endothelial cells isolated from rat peripheral blood. (**A**) Endothelial colony-forming cells isolated from rat peripheral blood as observed on day 7. (**B**,**C**) Tube formation assay of endothelial cells in the Matrigel (**B**) after cell seeding and calcein AM staining (**C**). Bars indicate 100 µm.

Characteristics of oral mucosal cell sheets with or without pre-vascularization {#Sec4}
-------------------------------------------------------------------------------

About 18 days after the cell culture, the fibrin glue, submucosal fibroblasts, and endothelial cells were mixed, poured, and solidified in the insert well. Next, the keratinocytes were seeded on the mixture. Five days later, the mucosal cell sheet was constructed and prepared for transplantation. The sheets were also easily detached using fine-tip forceps without an enzymatic detachment solution, transferred to other dishes, and prepared for grafting.

The histological examinations of the oral mucosal cell sheets exhibited similarities with the histological characteristics of the oral mucosa. The epithelial layer of the cell sheet included two to four layers of cuboidal-shaped nucleated epithelial cells interspersed with elongated cells (Fig. [3](#Fig3){ref-type="fig"}). The subepithelial layer of the PV cell sheet included fibroblasts, endothelial cells, and fibrin embedded in the scaffold, similar to the structures of the extracellular matrix in the oral mucosa. The K cell sheet included an upper layer of keratinocytes and a lower layer of fibrin matrix without any cells. In the PV sheet, the upper keratinocyte layer contained p63-positive cells and the lower pre-vascularization layer exhibited CD31-positive capillary-like structures (Fig. [3C,D](#Fig3){ref-type="fig"}).Figure 3Morphology of the cell sheets with and without pre-vascularization. (**A**) A mucosal cell sheet without pre-vascularization (K sheet) and with only keratinocytes overlaid on a fibrin matrix not including any cells. (**B**) A mucosal cell sheet with pre-vascularization (PV sheet) including the mixture of plasma fibrin, oral fibroblasts, and endothelial progenitor cells beneath the keratinocyte layer. (**C**,**D**) p63 immunofluorescence staining (green) in the keratinocyte layer of the PV sheet (**C**) and CD31 immunofluorescence staining in the pre-vascularization layer of the PV sheet (**D**). DAPI was used as the nuclear counterstains (blue). (**E**,**F**) Immunohistochemical staining of p63 (**E**) and CD31 (**F**) in the rat normal buccal mucosa. Bars indicate 50 µm.

Oral wound healing using a cell sheet with or without pre-vascularization {#Sec5}
-------------------------------------------------------------------------

Following deep oral wounding, the wound closure was completed in 14−21 days in rats with or without cell sheets. The re-epithelialization and wound closure occurred more rapidly in the K and PV sheet groups than in the control (*P* \< 0.05; Fig. [4](#Fig4){ref-type="fig"}). The remaining wounds were larger in the wound control than in the K and PV sheet groups (*P* \< 0.05). The cell sheet covering the oral defect appeared to be viable during early postoperative days. The PV sheet group exhibited earlier wound closure and smaller wound sizes than the K sheet group (*P* \< 0.05).Figure 4Comparison of gross wound healing among the wound control, K sheet, and PV sheet. (**A**) Photographs taken on days 7, 14, and 21 after deep surgical wounding of the rat buccal region. \*Arrows indicate unhealed wounds. (**B**) Comparison of wound sizes among the different groups. The wound size was measured regularly and was represented relative to that of a surgical defect on day 0. \**P* \< 0.05 relative to the wound control and the other mucosal sheet groups.

Following oral wounding, the microscopic examinations of surgical wounds supported the macroscopic findings and differences between the control and mucosal cell sheet groups (Fig. [5](#Fig5){ref-type="fig"}). The wound control exhibited elevated inflammatory reactions and sloughs covering the epithelial defects during the early postoperative stage. On day 7, the vessel number was higher for the PV sheet than the wound control or the K sheet (*P* \< 0.05, Fig. [5D,E](#Fig5){ref-type="fig"}). On days 14 and 28, the vessel number was higher in the wound control than in the K and PV sheets. The proliferating cells that stained positive for Ki67 were higher in the wound control than in the K and PV sheets on days 7, 14, and 28 (*P* \< 0.05, Fig. [5F,G](#Fig5){ref-type="fig"}). The wounds covered with cell sheets in the K sheet group exhibited a greater number of proliferating cells than those in the PV sheet group on days 7, 14, and 28.Figure 5Early microscopic healing and vessel counts in the oral wounds of rats in the different groups. (**A**--**C**) Comparison of early microscopic wound healing using Masson's trichrome staining among the wound control (**A**), the K sheet without pre-vascularization (**B**), and the PV sheet with pre-vascularization (**C**) on postoperative day 7. (**D**,**E**) Comparison of the quantification of microvessels stained with CD31 among the different groups. (**F**,**G**) Comparison of the quantification of proliferating cells stained with Ki67 among the different groups. The number of vessels and proliferating cells was measured on days 7, 14, and 28 after wounding. \**P* \< 0.05 between groups. The representative images (**D**,**F**) were from the PV sheet group on day 7. Bars indicate 50 µm.

During the later stage of wound healing, the epithelial and subepithelial compositions in the cell sheet groups were more similar to those of the unwounded normal buccal mucosa, whereas the epithelium and subepithelium in the wound control displayed increased fibrosis. The characteristics of the epithelium and subepithelium healed after wounding were measured on postoperative days 14 and 28 and then compared with those in the wound control, K sheet, and PV sheet groups and normal unwounded buccal mucosa (Fig. [6](#Fig6){ref-type="fig"}). The relative intensity of α-smooth muscle actin was increased in the wounds (with or without cell sheets) compared with that in the normal oral mucosa; this intensity was higher in the wound control than in the K and the PV sheet groups (Fig. [6E,F](#Fig6){ref-type="fig"}). The subepithelium exhibited thickening and increased collagen deposition in the wound control on days 14 and 28 compared with those of the normal buccal mucosa (*P* \< 0.05) (Fig. [6G](#Fig6){ref-type="fig"}). Increased collagen deposition was observed on day 14, which was decreased on day 28 (*P* \< 0.05). On both postoperative days, greater collagen deposition was observed in the control wound than in the K and PV sheet groups (*P* \< 0.05). On postoperative day 28, the mucosal thickness in the PV sheet group had recovered to that of the normal buccal mucosa; less in the K sheet group and much less in the wound control (*P* \< 0.05; Fig. [6H](#Fig6){ref-type="fig"}). The collagen deposition and epithelial thickness in the K sheet group appeared to be less normalized compared with that in the PV sheet group (*P* \< 0.05). The composition of the healed epithelium and subepithelium in the PV sheet group appeared highly similar to that of the normal rat buccal mucosa. Microscopic muscular disruption was identified in the buccal mucosa of the wounded controls but not in the PV sheet group.Figure 6Late microscopic healing of the oral wounds for of rats in the different groups. (**A**--**D**) Comparison of late microscopic wound healing using Masson's trichrome staining of the wound control (**A**), the K sheet without pre-vascularization (**B**), and the PV sheet with pre-vascularization (**C**) on postoperative day 28 and of the normal unwounded buccal mucosa (**D**). (**E**--**H**) Comparison of the quantification of myofibroblasts, collagen deposition, and epithelial thickness among the different groups on days 14 and 28 after wounding. The myofibroblasts were stained with α-smooth muscle actin (**E**), and the immunostaining intensity was measured using ImageJ software relative to the normal buccal mucosa (**F**). The representative images (**E**) were from the wound control (upper panel) on day 28 and the normal buccal mucosa (lower panel). Collagen density was quantified in the image exhibiting Masson's trichrome staining (**G**). The epithelium thickness was also compared among the groups (**H**). \**P* \< 0.05 between the groups. Bars indicate 50 µm.

Discussion {#Sec6}
==========

The present study demonstrated that the pre-vascularized mucosal cell sheet promoted the accelerated healing of deep oral wounds. The *in vitro* culture and expansion of oral keratinocytes, fibroblasts, and endothelial progenitor cells were successful after harvesting the oral mucosa and peripheral blood samples. Endothelial progenitor cells were isolated from peripheral blood, induced to form colonies, and expanded to prepare the microvessel pre-formation on the cell sheets. *In vitro* engineering of pre-vascularized oral mucosal cell sheets was also successful using the mixture of plasma fibrin, oral fibroblasts, and endothelial cells underneath the keratinocyte layer. The pre-vascularized oral mucosal cell sheets promoted oral wound healing with early wound closure in an *in vivo* rat model. The gross and histological healing of the oral wounds covered with the pre-vascularized sheet appeared to occur rapidly and naturally, and the oral mucosa of the wounded tissue eventually appeared similar to the normal oral mucosa without scarring and fibrosis. Our newly developed pre-vascularized mucosal cell sheets can be used to restore the oral mucosal lining and tissue defects by promoting oral wound healing. Therefore, this study is the first to demonstrate the potential applicability of pre-vascularized mucosal cell sheets in oral wound healing.

Endothelial colony-forming cells are found in peripheral blood, which can be used as an alternative source of vascular-derived endothelial cells^[@CR24]^. In addition, functional vascular networks with *in vivo* vasculogenic potential can be created from blood-derived endothelial progenitor cells using a Matrigel-supported cell transplantation method^[@CR25]^. Moreover, these endothelial progenitor cells have the potential to pre-form microvessels in the *in vitro*-engineered sheets and promote the *in vivo* vascularization of engineered tissues^[@CR26]^. After the transplantation of engineered cell sheets, functional vessel structure and vessel sprouting are formed by the networked endothelial progenitor cells in engrafted cell sheet constructs^[@CR27]^. The co-culture of endothelial cells and fibroblasts in fibrin-based constructs increases the vasculogenic activity of the endothelial cells via the direct communication between these cells and induces neovascularization after the transplantation^[@CR28],\ [@CR29]^. Based on previous research, we successfully constructed a pre-vascularized mucosal cell sheet comprising a high density of oral mucosal fibroblasts and blood-derived endothelial progenitor cells underlying a keratinocyte layer. In the present study, the pre-vascularization led to the neovascularization of the wounds in the early stage, which might have contributed to the survival of tissue-engineered cell sheets in the wound beds.

There is growing evidence that cell sheet technology can recover the oral mucosal defects by promoting wound re-epithelialization and neovascularization^[@CR8]--[@CR10]^. Following transplantation, graft survival is critical to the repair of intraoral defects. Moreover, graft survival has relied on plasmatic diffusion from the wound bed during the early stages after transplantation^[@CR30]^. The fibroblasts in the *in vitro*-engineered grafts and wounds might help the growth and maturation of keratinocytes to adapt under conditions of a defective oral mucosal lining; thus, the cultured fibroblasts provide growth factors that stimulate early wound healing^[@CR31],\ [@CR32]^. Our pre-vascularized cell sheet also further highlights the *in vivo* efficacy of oral wound healing in terms of early neovascularization and the adaptation of the grafted cell sheets to the host tissues.

Pre-vascularization has emerged as a promising concept in cell sheet engineering, which is aimed at the generation of pre-formed microvessels in constructs prior to transplantation^[@CR33]^. The neovascularization of three-dimensional cell sheet constructs was directly affected by the presence of human dermal microvascular endothelial cells; moreover, the synergistic interaction of endothelial cells and dermal fibroblasts contributed to neovascularization and skin wound re-epithelialization^[@CR34]^. A recent report revealed that human mesenchymal stem cell sheets pre-vascularized with human umbilical vein endothelial cells improved full-thickness skin wound repair by providing pre-formed microvessels^[@CR21]^. In this same study, the pre-vascularization induced the highest neovascularization during the early stages and improved wound repair^[@CR21]^. Moreover, pre-vascularized tissue engineering techniques have also been applied to the generation of buccal mucosal equivalents by utilizing a primary tri-culture of human gingival epithelial cells, fibroblasts, and dermal microvascular endothelial cells in a collagen membrane scaffold^[@CR35]^. In contrast, the present autologous pre-vascularized mucosal cell sheets used cells and plasma fibrin obtained from rats without the use of nonautologous or allogenic scaffolds to generate cell sheet constructs. Our autologous cell sheet immediately adapted well to the mucosal lining defect, resulting in the promotion of re-epithelialization and decreased fibrotic wound healing.

Oral mucosal cell sheets appeared to promote early wound closure and to decrease scarring in oral wounds. The *in vivo* effects of oral wound healing were more apparent in the rats treated with pre-vascularized cell sheets than in rats treated without pre-vascularization. Oral surface or soft tissue defects are commonly covered with split-thickness skin grafts or local/regional/free tissue transplantation, which is associated with increased morbidity of the donor site, considerable operation time, and specific surgical skills. In addition, epithelial cell sheets have been used as a potential material for application to grafts^[@CR6],\ [@CR7]^. The current study also suggested that mucosal pre-vascularized cell sheets can be used to re-surface oral mucosal defects in addition to the cultured epidermal cell sheets^[@CR36]^. After transplantation, the cell sheet grafted in the intraoral wounds survived well and contributed to oral wound healing. Inflammation at the wound site is an important determinant of wound healing processes. An excessively activated inflammatory response might hinder the regeneration process and eventually lead to hypertrophic scar contraction and fibrosis^[@CR37],\ [@CR38]^. The present study demonstrated that autologous mucosal sheet grafting was well adapted and survived in the surgical wound. The pre-vascularized grafts also improved wound neovascularization and prevented the induction of an excessive inflammatory response and granulation in the wounds, eventually resulting in a more natural wound healing process. During the later stages, the numbers of vessels and proliferating cells, and collagen deposition were not excessive in the PV group, compared to the K group or the control, which might result from potential modulation of wound healing by the pre-vascularized cell sheet. This also contributed to the natural healing of oral wounds, which mimicked the histological characteristics of the oral mucosa. One potential limitation of our study was that we did not use a skin graft or other types of various cell sheets as a control treatment for comparison with the mucosal cell sheet. Nonetheless, our study demonstrated the potential applicability of pre-vascularized oral mucosal cell sheets in oral wound healing.

In conclusion, the present study demonstrated the potential utility of our newly developed pre-vascularized oral mucosal cell sheet in deep oral wound healing. Pre-vascularized oral mucosal cell sheets can be generated *in vitro* from completely autologous sources of plasma fibrin, oral mucosal keratinocytes, fibroblasts, and endothelial progenitor cells from peripheral blood. Oral mucosal cell sheets with pre-formed microvessels have the potential to treat oral wounds by promoting healing via rapid closure and decreased fibrosis. Therefore, our *in vitro*-engineered pre-vascularized mucosal cell sheet approach may be useful to rapidly and naturally heal intraoral wounds.

Materials and Methods {#Sec7}
=====================

Isolation and *in vitro* culture of oral mucosal and endothelial progenitor cells {#Sec8}
---------------------------------------------------------------------------------

All animal experiments were performed in accordance with the protocols approved by Laboratory of Animal Research of Asan Institute for Life Sciences. Small pieces of the oral mucosa were sampled from the normal oral mucosa of 7-week-old Sprague Dawley (SD) rats purchased from Central Lab Animal Inc. (Seoul, Republic of Korea). The tissue samples were sterilized with povidone--iodine (Sigma-Aldrich, St. Louise, MO, USA) and washed thrice with a phosphate-buffered saline solution. All tissues were treated with 1-U/mL dispase (STEMCELL Technologies, Vancouver, Canada) for 1 h at 37 °C, and subsequently, epithelial and subepithelial layers were separated. Both layers were separately treated with trypsin--ethylenediaminetetraacetic acid (ThermoFisher Scientific, Waltham, MA, USA) for 30 min at 37 °C. The cells were separately seeded into culture dishes and grown in a culture medium comprising a 3:1 mixture of Dulbecco's modified Eagle's minimal essential medium and Ham's F12 (ThermoFisher), supplemented with 10% fetal bovine serum (ThermoFisher), recombinant insulin (5 µg/mL), triiodothyronine (1.3 ng/mL), adenine (24 µg/mL), hydrocortisone (0.4 µg/mL), and cholera toxin (8 ng/mL) (all purchased from Sigma-Aldrich), as well as with a penicillin/streptomycin/amphotericin antibiotic--antimycotic solution (ThermoFisher). Recombinant epidermal growth factor (10 ng/mL; ThermoFisher) was also added to the mucosal keratinocyte culture medium. The medium and supplements were replaced every 3 days.

Autologous circulating endothelial progenitor cells were isolated and cultured from peripheral mononuclear cells of the oral mucosal samples of each experimental rat using a diluted whole blood incubation technique, as previously described^[@CR23],\ [@CR39]^. Peripheral blood from the same rat was obtained and anticoagulated with 20-USP heparin units/mL blood (Sigma-Aldrich). The blood was diluted 1:4 with full endothelial cell growth medium (Lonza Ltd., Basel, Switzerland) and seeded onto culture plates pre-coated with type I collagen (5 μg/cm^2^, Sigma-Aldrich). The diluted whole blood was incubated at 37 °C in 5% CO~2~ atmosphere. The non-adherent cells and plasma were slowly removed every 24 h and replaced with new medium.

The cultured endothelial cells were seeded in 24 wells coated with 70-μL Matrigel at a cell density of 5 × 10^5^ cells per well and incubated at 37 °C. The capillary-like formation of the endothelial cells was photographed using an inverted microscope (Leica Biosystems, Wétzlar, Germany). The cultured endothelial cells and tube formation were stained with CD31 antibody (Novus International, St Louis, MO, USA) and calcein AM (Sigma).

Generation of *in vitro*-engineered mucosal cell sheet with and without pre-vascularization {#Sec9}
-------------------------------------------------------------------------------------------

Fibrin glue prepared from the plasma of the same rat was used as the source of the scaffolds for the cell sheets. This fibrin glue comprised a mixture of 0.3-mL plasma, 1% calcium chloride, 50-µL tranexamic acid (Santa Cruz Biotechnology, Inc., Dallas, TX, USA), and 0.3-mL medium including 5 × 10^5^ fibroblasts and 5 × 10^5^ endothelial cells for pre-vascularization (called as the PV sheet) (Fig. [1A](#Fig1){ref-type="fig"}). The mixture was solidified in transwell cell culture inserts containing a 0.4-mm-pore polyester membrane (Corning, Inc., Corning, NY, USA) at 37 °C for 60 min. The inserts were placed in the plates with medium and supplements. The keratinocytes were seeded on the mixture of fibrin glue, fibroblasts, and endothelial cells and were grown under air--liquid interface culture conditions containing the same medium, autologous serum, and supplements as mentioned above. Another type of cell sheet was generated using the fibrin matrix without any cells immediately below the keratinocyte layer (K sheet).

The *in vitro*-cultured mucosal cell sheet samples were harvested, embedded in optimal cutting temperature compound (Sakura Fineteck USA Inc., Torrance, CA, USA), immediately snap-frozen in liquid nitrogen, and stored at −80 °C for subsequent use. The stored sheet or tissue samples were prepared into 5-µm-thick frozen sections for histological examination. The sections were stained with hematoxylin and eosin (Sigma-Aldrich). The samples were also examined after staining with p63 (1:100 dilution, Abcam, Cambridge, UK) or CD31 (1:100 dilution, Novus International, St. Louis, MO, USA) according to the immunofluorescence staining protocol and examined using fluorescence microscopy (Olympus Co. Tokyo, Japan).

Oral wound model and *in vivo* testing of cell sheets {#Sec10}
-----------------------------------------------------

The SD rats were anesthetized via an intramuscular injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). The mucosa and submucosal soft tissues in the buccal region of each rat were removed with iris scissors to create an approximately 75-mm^2^-sized wound (Fig. [1B--D](#Fig1){ref-type="fig"}). The wound was made about 23 days after oral mucosal biopsy in the same rats. The autologous oral mucosal cell sheets were detached from the culture dishes and moved to the oral defect. The cell sheet was fixed onto the wound with 5-0 nylon sutures and then overlaid with a thin transparent silastic sheet (0.010″ thickness; Bentec Medical, Woodland, CA, USA). The control wound was covered with a silastic sheet but no cell sheets. All silastic sheets were removed 5 days after grafting. The experiment included 45 rats and each rat had bilateral oral buccal wounds, including the ipsilateral wound control and treatments using either the PV or K sheets. Five rats were also used as the unwounded control for a histological examination of rat normal buccal mucosa compared with that of the experimental rats treated with or without the cell sheets.

Gross and microscopic examinations of oral wounds {#Sec11}
-------------------------------------------------

Gross photographs of each rat wound were taken and the wound sizes were measured regularly after wounding. Ten rats, including the K sheets (*n* = 5) and the PV sheets (*n* = 5), were sacrificed on postoperative days 7, 14, 21, and 28, and the tissues from the previous wounds were harvested. Thereafter, 5-µm-thick sections were stained with hematoxylin--eosin and Masson's trichrome stains (Sigma-Aldrich) and observed under a light microscope (Nikon co., Tokyo, Japan).

The tissues were stained with hematoxylin and eosin, Masson's trichrome, and immunostained with CD31 (1:200 dilution, Novus International), Ki67 (1:200 dilution, Abcam), and α-smooth muscle actin (1:200, Abcam). The CD31 or Ki67-positive vessels were counted at a high-power field. The intensity of positive α-smooth muscle actin immunostaining was measured using the NIH ImageJ software (National Institutes of Health \[NIH\], Bethesda, MD, USA) and the relative intensities to normal buccal mucosa were compared among the different groups^[@CR40],\ [@CR41]^. Collagen density^[@CR21],\ [@CR42]^ and epithelial thickness^[@CR21],\ [@CR43]^ were measured in a blind manner in 10 randomly selected fields using the NIH ImageJ processing program.

Statistical analysis {#Sec12}
--------------------

The data were presented as the mean ± standard deviation. The statistical significance of the differences among the various treatment groups was assessed using a Mann--Whitney *U*-test. The statistical differences among the different periods in each group were assessed using the Wilcoxon singed-rank test. Statistical significance was defined as a two-sided *P* value \< 0.05, using SPSS version 23.0 statistical software (IBM, Armonk, NY, USA).
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